Cargando…

Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?

OBJECTIVE: To investigate the association of inflammatory markers with severity of intrahepatic cholestasis of pregnancy (ICP). MATERIALS AND METHODS: This retrospective case-control study was conducted with 229 pregnant women, 84 with ICP, and 145 age-matched healthy pregnant women. Patients were c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yayla Abide, Çiğdem, Vural, Fisun, Kılıççı, Çetin, Bostancı Ergen, Evrim, Yenidede, İlter, Eser, Ahmet, Pekin, Oya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651890/
https://www.ncbi.nlm.nih.gov/pubmed/29085705
http://dx.doi.org/10.4274/tjod.67674
_version_ 1783272969671278592
author Yayla Abide, Çiğdem
Vural, Fisun
Kılıççı, Çetin
Bostancı Ergen, Evrim
Yenidede, İlter
Eser, Ahmet
Pekin, Oya
author_facet Yayla Abide, Çiğdem
Vural, Fisun
Kılıççı, Çetin
Bostancı Ergen, Evrim
Yenidede, İlter
Eser, Ahmet
Pekin, Oya
author_sort Yayla Abide, Çiğdem
collection PubMed
description OBJECTIVE: To investigate the association of inflammatory markers with severity of intrahepatic cholestasis of pregnancy (ICP). MATERIALS AND METHODS: This retrospective case-control study was conducted with 229 pregnant women, 84 with ICP, and 145 age-matched healthy pregnant women. Patients were categorized as mild ICP (<40 µmol/L) and severe ICP (≥40 µmol/L) with regard to serum bile acids. Inflammatory markers (neutrophil-to-lymphocyte ratio (NLR), platelet-to- lymphocyte ratio (PLR) and mean platelet volume (MPV), and red blood cell distribution width (RDW) were compared between the groups. RESULTS: Patients with ICP had significantly decreased RDW and increased white blood cell counts (WBC), MPV and PLR, but no significant changes in NLR. The comparison of mild and severe cases with regard to NLR, PLR, WBC, and RDW was similar (p>0.05). MPV levels were significantly increased in severe group (p<0.05). CONCLUSION: WBC, MPV, and PLR were the inflammatory markers significantly increased, and RDW was signifantly reduced in ICP. MPV was the marker that significantly increased with the severity of disease. The use of inflammatory markers in the assessment of perinatal outcomes needs further studies.
format Online
Article
Text
id pubmed-5651890
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-56518902017-10-30 Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers? Yayla Abide, Çiğdem Vural, Fisun Kılıççı, Çetin Bostancı Ergen, Evrim Yenidede, İlter Eser, Ahmet Pekin, Oya Turk J Obstet Gynecol Clinical Investigation OBJECTIVE: To investigate the association of inflammatory markers with severity of intrahepatic cholestasis of pregnancy (ICP). MATERIALS AND METHODS: This retrospective case-control study was conducted with 229 pregnant women, 84 with ICP, and 145 age-matched healthy pregnant women. Patients were categorized as mild ICP (<40 µmol/L) and severe ICP (≥40 µmol/L) with regard to serum bile acids. Inflammatory markers (neutrophil-to-lymphocyte ratio (NLR), platelet-to- lymphocyte ratio (PLR) and mean platelet volume (MPV), and red blood cell distribution width (RDW) were compared between the groups. RESULTS: Patients with ICP had significantly decreased RDW and increased white blood cell counts (WBC), MPV and PLR, but no significant changes in NLR. The comparison of mild and severe cases with regard to NLR, PLR, WBC, and RDW was similar (p>0.05). MPV levels were significantly increased in severe group (p<0.05). CONCLUSION: WBC, MPV, and PLR were the inflammatory markers significantly increased, and RDW was signifantly reduced in ICP. MPV was the marker that significantly increased with the severity of disease. The use of inflammatory markers in the assessment of perinatal outcomes needs further studies. Galenos Publishing 2017-09 2017-09-30 /pmc/articles/PMC5651890/ /pubmed/29085705 http://dx.doi.org/10.4274/tjod.67674 Text en ©Copyright 2017 by Turkish Society of Obstetrics and Gynecology Turkish Journal of Obstetrics and Gynecology published by Galenos Publishing House. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigation
Yayla Abide, Çiğdem
Vural, Fisun
Kılıççı, Çetin
Bostancı Ergen, Evrim
Yenidede, İlter
Eser, Ahmet
Pekin, Oya
Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?
title Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?
title_full Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?
title_fullStr Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?
title_full_unstemmed Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?
title_short Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?
title_sort can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?
topic Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651890/
https://www.ncbi.nlm.nih.gov/pubmed/29085705
http://dx.doi.org/10.4274/tjod.67674
work_keys_str_mv AT yaylaabidecigdem canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers
AT vuralfisun canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers
AT kılıccıcetin canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers
AT bostancıergenevrim canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers
AT yenidedeilter canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers
AT eserahmet canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers
AT pekinoya canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers